RSS-Feed abonnieren
DOI: 10.3414/ME15-01-0081
Standard Information Models for Representing Adverse Sensitivity Information in Clinical Documents
Publikationsverlauf
received:
02. Mai 2015
accepted:
30. Januar 2016
Publikationsdatum:
08. Januar 2018 (online)
Summary
Background: Adverse sensitivity (e.g., allergy and intolerance) information is a critical component of any electronic health record system. While several standards exist for structured entry of adverse sensitivity information, many clinicians record this data as free text.
Objectives: This study aimed to 1) identify and compare the existing common adverse sensitivity information models, and 2) to evaluate the coverage of the adverse sensitivity information models for representing allergy information on a subset of inpatient and outpatient adverse sensitivity clinical notes.
Methods: We compared four common adverse sensitivity information models: Health Level 7 Allergy and Intolerance Domain Analysis Model, HL7-DAM; the Fast Health-care Interoperability Resources, FHIR; the Consolidated Continuity of Care Document, C-CDA; and OpenEHR, and evaluated their coverage on a corpus of inpatient and out-patient notes (n = 120).
Results: We found that allergy specialists’ notes had the highest frequency of adverse sensitivity attributes per note, whereas emergency department notes had the fewest attributes. Overall, the models had many similarities in the central attributes which covered between 75% and 95% of adverse sensitivity information contained within the notes. However, representations of some attributes (especially the value-sets) were not well aligned between the models, which is likely to present an obstacle for achieving data interoperability. Also, adverse sensitivity exceptions were not well represented among the information models.
Conclusions: Although we found that common adverse sensitivity models cover a significant portion of relevant information in the clinical notes, our results highlight areas needed to be reconciled between the stand -ards for data interoperability.
-
References
- 1 American_Academy_of_Asthma_and_Immunology.. AAAAI Allergy, Asthma and Immunology Dictionary. 2015 http://www.aaaai.org/conditions-and-treatments/conditions-dictionary.aspx (accessed 1 Apr2015).
- 2 Asthma and Allergy Foundation of America.. Common facts and figures. 2014 http://www.aafa.org/display.cfm?id=9&sub=30 (accessed Apr 1, 2015).
- 3 Finnell J, Dixon B. Clinical Informatics Study Guide – Text and Review. Philadelphia: Springer; 2016. http://www.springer.com/us/book/9783319227528 (accessed Dec 7, 2015).
- 4 Dolin RH, Rogers B, Jaffe C. Health level seven interoperability strategy: big data, incrementally structured. Methods Inf Med 2015; 54: 75-82. doi:10.3414/ME14-01-0030
- 5 Office of National Cooridnator for Health IT. Consolidated CDA Overview. 2014 http://www.healthit.gov/policy-researchers-implementers/consolidated-cda-overview (accessed Apr 1, 2015).
- 6 openEHR.. openEHR: An open domain-driven platform for developing flexible e-health systems. 2014.http://www.openehr.org (accessed Feb 23, 2015).
- 7 Goss F, Plasek J, Lau J. et al. An Evaluation of a Natural Language Processing Tool for Identifying and Encoding Allergy Information in Emergency Department Clinical Notes. AMIA Annu Symp Proc 2014; 1: 580-588.
- 8 Friedman C. Discovering Novel Adverse Drug Events Using Natural Language Processing and Mining of the Electronic Health Record. Berlin, Heidelberg: Springer; 2009. doi:10.1007/ 978-3-642-02976-9.
- 9 Melton GB, Hripcsak G. Automated detection of adverse events using natural language processing of discharge summaries. J Am Med Inform Assoc 2005; 12: 448-457. doi:10.1197/jamia.M1794
- 10 Rosenbloom ST, Denny JC, Xu H. et al. Data from clinical notes: a perspective on the tension between structure and flexible documentation. J Am Med Inform Assoc 2011; 18: 181-186. doi:10.1136/jamia.2010.007237
- 11 Bouamrane M, Tao C, Sarkar IN. Managing interoperability and complexity in health systems. Methods Inf Med 2015; 54: 1-4. doi:10.3414/ME15–10–0001
- 12 HL7.. HL7 Version 3 Domain Analysis Model: Allergy and Intolerance. 2014 http://www.hl7.org/implement/standards/prouct_brief.cfm?product_id=308 (accessed Apr 1, 2015).
- 13 FHIR.. FHIR Overview. 2014 http://www.hl7.org/implement/standards/fhir/overview.html (accessed Apr 1, 2015).
- 14 Ogren P. Knowtator. 2009 http://knowtator.sourceforge.net/index.shtml (accessed Mar 30, 2015).
- 15 Charles A, Janeway J, Travers P, Walport M. et al. Immunobiology: The Immune System in Health and Disease. 5th ed. New York: Garland Science; 2001. http://www.ncbi.nlm.nih.gov/books/NBK10756/ (accessed 7 Dec2015).
- 16 Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions – new concepts. Clin Exp Allergy 2007; 37: 989-999. doi:10.1111/j.1365-2222.2007.02742.x
- 17 FHIR.. AllergyIntolerance – FHIR: Criticality vs Severity. 2014 http://www.hl7.org/implement/standards/fhir/allergyintolerance.html (accessed Apr 1, 2015).
- 18 Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259. doi:10.1016/S0140-6736(00)02799-9.